Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sung Min Chun"'
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 10, Pp 3197-3204 (2021)
Cancer Medicine, Vol 10, Iss 10, Pp 3197-3204 (2021)
Purpose This study investigated the clinical utility of next‐generation sequencing (NGS) for detection of genetic alterations and its implications on treatment of lung adenocarcinoma in real‐world practice. Patients and Methods Data were reviewed
Autor:
Chang Ohk Sung, Insuk Sohn, Jihun Kim, Eun Jeong Cho, Sung-Min Chun, Se Jin Jang, Ji-Young Lee, Ji-Hye Oh
Publikováno v:
npj Genomic Medicine, Vol 5, Iss 1, Pp 1-11 (2020)
Tumor mutation burden (TMB) is an emerging biomarker, whose calculation requires targeted sequencing of many genes. We investigated if the measurement of mutation counts within a single gene is representative of TMB. Whole-exome sequencing (WES) data
Autor:
Tae-Yon Sung, Eun-Gyoung Hong, Won Gu Kim, Yun Mi Choi, Dong Eun Song, Se Jin Jang, Jinyeong Lim, Min Ji Jeon, Sung-Min Chun, Ji-Young Lee, Yu-Mi Lee
Publikováno v:
Cancers, Vol 13, Iss 2389, p 2389 (2021)
Cancers
Volume 13
Issue 10
Cancers
Volume 13
Issue 10
Simple Summary Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors arising from chromaffin cells of the adrenal medulla, or extra-adrenal paraganglia, respectively. In PPGLs, germline or somatic mutations in one of the known suscep
Autor:
Hyung-Joo Oh, Hyun-Ju Cho, Cheol-Kyu Park, Hyung-Jeong Yang, Bo-Gun Koh, Young-Chul Kim, Min-Seok Kim, Ji-Young Lee, Sung-Min Chun, In-Jae Oh
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: This study aimed to investigate the feasibility of using circulating tumor cells (CTCs), peripheral blood cells (PBCs), and circulating cell-free DNA (cfDNA) as biomarkers of immune checkpoint inhibitor treatment response in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f7551e8df63bbbaea7fd4395974586
https://europepmc.org/articles/PMC8182702/
https://europepmc.org/articles/PMC8182702/
Autor:
Seo Young Park, Youngheun Jo, Soo Jung Nam, Ho Sung Kim, Jeong Hoon Kim, Sung-Min Chun, Ji Eun Park
Publikováno v:
Radiology. 294(2)
Background Next-generation sequencing (NGS) enables highly sensitive cancer genomics analysis, but its clinical implications for therapeutic options from imaging-based prediction have been limited. Purpose To predict core signaling pathways in isocit
Autor:
Tae Im Kim, Hyung-Sik Shin, Mineui Hong, Byung Chun Kim, Jeong Won Kim, Young Woong Ko, Seung-Mo Hong, Eunsil Yu, Jihun Kim, Mi Kyung Shin, Sung-Min Chun, Se-Jin Jang, Kyung-Chan Choi
Publikováno v:
Human Pathology. 65:21-30
Summary Tumor budding (TB) in colorectal carcinoma (CRC) is related to epithelial-mesenchymal transition and has been recently characterized as an indicator of poor prognosis along with lymphovascular tumor emboli, perineural invasion, and an infiltr
Autor:
Nayoung K.D. Kim, Chang Ohk Sung, Woong-Yang Park, Jihun Kim, Yoon-La Choi, Sung-Min Chun, Hyo Sup Shim, Jene Choi, Se Jin Jang, Young-Hyeh Ko, Jae Kyung Won
Publikováno v:
Journal of Pathology and Translational Medicine
Journal of Pathology and Translational Medicine, Vol 51, Iss 3, Pp 191-204 (2017)
Journal of Pathology and Translational Medicine, Vol 51, Iss 3, Pp 191-204 (2017)
Next-generation sequencing (NGS) has recently emerged as an essential component of personalized cancer medicine due to its high throughput and low per-base cost. However, no sufficient guidelines for implementing NGS as a clinical molecular pathology
Autor:
Soo Jin Jung, Sung-Min Chun, Soon Uk Hong, Jene Choi, Eui-Jin Lee, Sun-Young Jun, Gwang Il Kim, Mi-Ju Kim, Ghilsuk Yoon, Seung-Mo Hong, Joon Mee Kim, Young Kyung Bae, Jung Yeon Kim, Kee-Taek Jang
Publikováno v:
Oncotarget
// Sun-Young Jun 1 , Eui-Jin Lee 2 , Mi-Ju Kim 3 , Sung Min Chun 4 , Young Kyung Bae 5 , Soon Uk Hong 6 , Jene Choi 4 , Joon Mee Kim 7 , Kee-Taek Jang 8 , Jung Yeon Kim 9 , Gwang Il Kim 10 , Soo Jin Jung 11 , Ghilsuk Yoon 12 , Seung-Mo Hong 4 1 Depar
Autor:
Jae-Lyun Lee, Tae Won Kim, Kyu-Pyo Kim, Sung-Min Chun, Se Jin Jang, Jeong Eun Kim, Jihun Kim, Dalyong Kim, Yong Sang Hong
Publikováno v:
Cancer Research and Treatment. 49:37-43
Purpose Cetuximab demonstrates improved efficacy outcomes in patients with metastatic colorectal cancer (mCRC) harboring wild-type KRAS exon 2. Resistance to cetuximab is mediated by activating less frequent mutations in the RAS genes beyond KRAS exo
Autor:
Chang-Sik Yu, Tae Won Kim, Jiyun Kim, Se Jin Jang, Adnan Ahmad Ansari, Jihun Kim, In Ja Park, Sung-Min Ahn, Sung-Min Chun, Deokhoon Kim
Publikováno v:
Oncotarget
// Sung-Min Ahn 1, 2, * , Adnan Ahmad Ansari 3, 4, * , Jihun Kim 4, 5 , Deokhoon Kim 4 , Sung-Min Chun 4, 5 , Jiyun Kim 5 , Tae Won Kim 6 , Inja Park 7 , Chang-Sik Yu 7 , Se Jin Jang 4, 5 1 Division of Hematology-Oncology, Department of Internal Medi